What does Ikarian Capital, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Ikarian Capital, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

TERNS PHARMACEUTICALS INC

$140M2.7M11.4%

SPDR SERIES TRUST

$102M800K8.3%

CYTOKINETICS INC

$82M1.2M6.6%

INVESCO QQQ TR

$58M100K4.7%

KODIAK SCIENCES INC

$52M1.4M4.2%

ISHARES TR

$50M200K4.0%

ABIVAX SA

$39M351K3.2%

ALUMIS INC

$33M1.5M2.6%

BRISTOL-MYERS SQUIBB CO

$30M500K2.5%

CAPRICOR THERAPEUTICS INC

$27M878K2.2%

Filing history loading…